No connection

Search Results

ABBV vs BFLY

ABBV
AbbVie Inc.
NEUTRAL
Price
$219.26
Market Cap
$387.52B
Sector
Healthcare
AI Confidence
68%
BFLY
Butterfly Network, Inc.
NEUTRAL
Price
$4.51
Market Cap
$1.14B
Sector
Healthcare
AI Confidence
65%

Valuation

P/E Ratio
ABBV
163.63
BFLY
--
Forward P/E
ABBV
15.42
BFLY
-32.8
P/B Ratio
ABBV
-146.66
BFLY
5.59
P/S Ratio
ABBV
6.5
BFLY
12.88
EV/EBITDA
ABBV
15.27
BFLY
-16.66

Profitability

Gross Margin
ABBV
71.46%
BFLY
62.92%
Operating Margin
ABBV
35.5%
BFLY
-69.69%
Profit Margin
ABBV
4.0%
BFLY
-90.31%
ROE
ABBV
137.96%
BFLY
-41.42%
ROA
ABBV
9.59%
BFLY
-14.35%

Growth

Revenue Growth
ABBV
9.1%
BFLY
4.5%
Earnings Growth
ABBV
-88.7%
BFLY
--

Financial Health

Debt/Equity
ABBV
--
BFLY
0.1
Current Ratio
ABBV
0.72
BFLY
4.8
Quick Ratio
ABBV
0.47
BFLY
3.35

Dividends

Dividend Yield
ABBV
3.05%
BFLY
--
Payout Ratio
ABBV
490.15%
BFLY
0.0%

AI Verdict

ABBV NEUTRAL

The Advanced Deterministic Scorecard reveals a mixed health profile with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite robust operating margins and consistent revenue growth, the company faces significant headwinds from negative earnings growth, an extremely high P/E ratio, and a dangerously elevated payout ratio. Strong historical price performance and analyst buy sentiment are counterbalanced by bearish insider activity and deteriorating profitability trends. The stock appears to trade at a substantial premium to its intrinsic value, suggesting limited margin of safety.

Strengths
High operating margin (35.50%) indicating strong pricing power and cost control
Consistent revenue growth (9.10% YoY) outpacing sector average
Strong track record of earnings surprises (22 out of 25 quarters beat estimates)
Risks
Extremely high P/E ratio (163.63) vs forward P/E (15.42), suggesting potential overvaluation on trailing basis
Earnings growth collapsing (YoY: -88.70%, Q/Q: -88.10%) indicating severe profitability deterioration
Unsustainable dividend payout ratio (490.15%) threatening dividend security
BFLY NEUTRAL

Butterfly Network (BFLY) shows a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive bankruptcy risk assessment. Despite deeply negative profitability metrics—including a -90.31% profit margin and negative ROE/ROA—the company maintains strong liquidity (Current Ratio: 4.80) and a low Debt/Equity ratio of 0.10. Revenue growth is modest at 4.50% YoY, but earnings surprises have been consistently positive in recent quarters, suggesting operational improvements. However, aggressive insider selling worth $21.71M over the past six months contradicts the 'strong_buy' analyst consensus and raises concerns about insider confidence.

Strengths
Strong liquidity position with Current Ratio of 4.80 and Quick Ratio of 3.35
Low leverage with Debt/Equity ratio of 0.10, well below sector average of 2.28
High gross margin of 62.92%, indicating pricing power or efficient production
Risks
Piotroski F-Score of 5 indicates borderline financial stability; not strong enough to signal robust health
Severe unprofitability: -90.31% profit margin and -41.42% ROE suggest ongoing fundamental weaknesses
Negative Forward P/E of -32.80 implies no near-term earnings recovery priced in

Compare Another Pair

ABBV vs BFLY: Head-to-Head Comparison

This page compares AbbVie Inc. (ABBV) and Butterfly Network, Inc. (BFLY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile